Labeler
Par Health USA, LLC NDC Codes
Par Health USA, LLC lists 220 finished drug products in the FDA NDC Directory under NDC labeler codes 0254, 0603, 10370, 42023, 49884.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Adrenalin (epinephrine in sodium chloride), Dexmethylphenidate Hydrochloride, Lamotrigine Extended-Release, Ephedrine Sulfate, Topiramate, Everolimus, Vasostrict, Sitagliptin and Metformin hydrochloride, Pitocin, Benztropine Mesylate, Varenicline, sapropterin dihydrochloride, Nitisinone, Midodrine Hydrochloride, Sugammadex Sodium
- Active ingredients
- Epinephrine, Dexmethylphenidate hydrochloride, Lamotrigine, Ephedrine sulfate, Topiramate, Everolimus, Vasopressin, Unspecified, Sitagliptin phosphate, Metformin hydrochloride, Oxytocin, Benztropine mesylate, Sapropterin dihydrochloride
- NDC labeler codes
- 0254, 0603, 10370, 42023, 49884
- Strengths (from the 100 most recently listed products)
- Oxytocin 10 [iU]/mL; Sitagliptin phosphate 50 mg/1; Metformin hydrochloride 1000 mg/1; Ephedrine sulfate 5 mg/mL; Colchicine .6 mg/1; Vasopressin, Unspecified 20 [USP'U]/mL; Epinephrine 1 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Sapropterin dihydrochloride 100 mg/1; Penicillamine 250 mg/1; Phenylephrine hydrochloride 10 mg/mL; Ephedrine sulfate 50 mg/mL; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Metformin hydrochloride 500 mg/1; Sitagliptin phosphate 100 mg/1; Lamotrigine 100 mg/1; Lamotrigine 200 mg/1; Lamotrigine 300 mg/1; Lamotrigine 250 mg/1
- Dosage forms
- Injection, Tablet, Capsule, Capsule, Extended release, Tablet, Film coated, Tablet, Film coated, Extended release, Injection, Solution, Powder, For solution, Solution, Tablet, Delayed release, Injection, Powder, Lyophilized, For solution, Capsule, Delayed release, Capsule, Gelatin coated, Liquid, Kit, Suspension
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Sublingual
- Drug classes (FDA established)
- alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Catecholamine, Anti-epileptic Agent, Central Nervous System Stimulant, Mood Stabilizer, Norepinephrine Releasing Agent, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Anticholinergic, Antihistamine, Biguanide, Dipeptidyl Peptidase 4 Inhibitor, Oxytocic, Nonsteroidal Anti-inflammatory Drug, Phenylalanine Hydroxylase Activator, 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor, Opioid Antagonist, Reducing and Complexing Thiol, Alkaloid, Proton Pump Inhibitor, Vasopressin V2 Receptor Antagonist, Cholinergic Receptor Agonist, Partial Cholinergic Nicotinic Agonist, Muscle Relaxant, Chloride Channel Activator, Central alpha-2 Adrenergic Agonist, Antirheumatic Agent, alpha-1 Adrenergic Agonist, Renin Inhibitor, gamma-Aminobutyric Acid A Receptor Positive Modulator, Cholinesterase Inhibitor, Platelet Aggregation Inhibitor, Lipopeptide Antibacterial, Nitrogen Binding Agent, Tetracycline-class Drug, Histamine-2 Receptor Antagonist, Anti-coagulant, Direct Thrombin Inhibitor, Bismuth, Nitroimidazole Antimicrobial, Tetracycline-class Antimicrobial, Azole Antifungal, Cholinergic Muscarinic Antagonist, Nitrate Vasodilator, Calcitonin, Vitamin B6 Analog, Copper Chelator, Phenothiazine, Anthelmintic, Serotonin Reuptake Inhibitor
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 111 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Sugammadex Sodium | Sugammadex sodium 200 mg/2mL | SolutionIntravenous | 42023-830 | 42023-0830-10 | — |
| Sugammadex Sodium | Sugammadex sodium 500 mg/5mL | SolutionIntravenous | 42023-935 | 42023-0935-10 | — |
| Sitagliptin and Metformin hydrochloride | Sitagliptin phosphate 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-317 | 10370-0317-02 | — |
| Sitagliptin and Metformin hydrochloride | Sitagliptin phosphate 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-318 | 10370-0318-02 | — |
| Sitagliptin and Metformin hydrochloride | Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-351 | 10370-0351-11 | — |
| Lamotrigine Extended-Releaselamotrigine | Lamotrigine 100 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-207 | 10370-0207-11 | — |
| Lamotrigine Extended-Releaselamotrigine | Lamotrigine 200 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-208 | 10370-0208-11 | — |
| Lamotrigine Extended-Releaselamotrigine | Lamotrigine 300 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-256 | 10370-0256-11 | — |
| Lamotrigine Extended-Releaselamotrigine | Lamotrigine 250 mg/1 | Tablet, Film coated, Extended releaseOral | 10370-334 | 10370-0334-11 | — |
| Daptomycin | Daptomycin 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 42023-295 | 42023-0295-10 | — |
| Glycerol Phenylbutyrateglycerol phenylbutyrate oral | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | 49884-264 | 49884-0264-95 | — |
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride | Epinephrine 32 ug/mL | InjectionIntravenous | 42023-500 | 42023-0500-10 | J0171 |
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride | Epinephrine 8 ug/mL | InjectionIntravenous | 42023-273 | 42023-0273-10 | J0171 |
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride | Epinephrine 20 ug/mL | InjectionIntravenous | 42023-434 | 42023-0434-10 | J0171 |
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride | Epinephrine 40 ug/mL | InjectionIntravenous | 42023-721 | 42023-0721-10 | J0171 |
| Doxycycline | Doxycycline hyclate 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 42023-244 | 42023-0244-10 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 42023-224 | 42023-0224-01 | — |
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride | Epinephrine 16 ug/mL | InjectionIntravenous | 42023-315 | 42023-0315-10 | J0171 |
| Tiopronin | Tiopronin 100 mg/1 | Tablet, Delayed releaseOral | 0254-3034 | 00254-3034-30 | — |
| Tiopronin | Tiopronin 300 mg/1 | Tablet, Delayed releaseOral | 0254-3035 | 00254-3035-09 | — |
| Pitocinoxytocin | Oxytocin 10 [iU]/mL | InjectionIntravenous | 42023-116 | 42023-0116-93 | — |
| Ibuprofen and famotidine | Ibuprofen 800 mg/1; Famotidine 26.6 mg/1 | TabletOral | 49884-366 | 49884-0366-09 | — |
| Ephedrine Sulfate | Ephedrine sulfate 5 mg/mL | InjectionIntravenous | 42023-243 | 42023-0243-99 | — |
| Pitocinoxytocin | Oxytocin 10 [iU]/mL | InjectionIntravenous | 42023-116 | 42023-0116-7342023-0116-83 | — |
| Colchicine | Colchicine .6 mg/1 | CapsuleOral | 0254-0460 | 00254-0460-01 | — |
| Bivalirudin | Bivalirudin 250 mg/1 | Injection, SolutionIntravenous | 42023-622 | 42023-0622-0142023-0622-10 | — |
| Dexlansoprazole | Dexlansoprazole 30 mg/1 | Capsule, Delayed releaseOral | 49884-147 | 49884-0147-11 | — |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 10370-366 | 10370-0366-0110370-0366-11 | — |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 10370-365 | 10370-0365-0110370-0365-11 | — |
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 10370-367 | 10370-0367-0110370-0367-11 | — |
| Alvimopan | Alvimopan 12 mg/1 | CapsuleOral | 0254-3012 | 00254-3012-55 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 10370-368 | 10370-0368-0110370-0368-11 | — |
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | Bismuth subcitrate potassium 140 mg/1 + 2 more ingredients | CapsuleOral | 49884-151 | 49884-0151-54 | — |
| Diclofenac Potassium | Diclofenac potassium 50 mg/1 | Powder, For solutionOral | 49884-905 | 49884-0905-64 | — |
| Posaconazole | Posaconazole 18 mg/mL | InjectionIntravenous | 42023-195 | 42023-0195-01 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | 49884-160 | 49884-0160-02 | — |
| Vasostrictvasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | 42023-164 | 42023-0164-83 | — |
| Dexlansoprazole | Dexlansoprazole 60 mg/1 | Capsule, Delayed releaseOral | 49884-148 | 49884-0148-0949884-0148-11 | — |
| Colchicine | Colchicine .6 mg/1 | Tablet, Film coatedOral | 49884-171 | 49884-0171-0149884-0171-11 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | 49884-158 | 49884-0158-02 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | 49884-159 | 49884-0159-02 | — |
| Benztropine Mesylate | Benztropine mesylate .5 mg/1 | TabletOral | 0603-2433 | 00603-2433-2100603-2433-32 | — |
| Benztropine Mesylate | Benztropine mesylate 1 mg/1 | TabletOral | 0603-2434 | 00603-2434-2100603-2434-32 | — |
| Benztropine Mesylate | Benztropine mesylate 2 mg/1 | TabletOral | 0603-2435 | 00603-2435-2100603-2435-32 | — |
| Tolvaptan | Tolvaptan 30 mg/1 | TabletOral | 49884-770 | 49884-0770-54 | — |
| Tolvaptan | Tolvaptan 15 mg/1 | TabletOral | 49884-768 | 49884-0768-54 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | 49884-283 | 49884-0283-02 | — |
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | 49884-042 | 49884-0042-33 | — |
| Isosorbide Dinitrate | Isosorbide dinitrate 40 mg/1 | TabletOral | 49884-556 | 49884-0556-01 | — |
| Vasostrictvasopressin | Vasopressin, Unspecified .4 [USP'U]/mL | InjectionIntravenous | 42023-219 | 42023-0219-10 | — |
Par Health USA, LLC: common questions
- What is Par Health USA, LLC's NDC labeler code?
- 0254, 0603, 10370, 42023, 49884. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Par Health USA, LLC?
- Med-Code's HCPCS directory matches J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.